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Summary 
Leishmania major promastigotes were found to avoid activation of mouse bone marrow-derived 
macrophages (BMMo) in vitro for production of cytokines that are typically induced during 
infection with other intracellular pathogens. Coexposure of BMMo to the parasite and other 
microbial stimuli resulted in complete inhibition ofinterleukin (IL) 12 (p40) mRNA induction 
and IL-12 release. In contrast, mRNA and protein levels for IL-lot, IL-113, tumor necrosis fac- 
tor (TNF) ci, and inducible NO synthase (iNOS) were only partially reduced, and signals for 
IL-10 and monocyte chemoattractant protein (MCP-1/JE) were enhanced. The parasite could 
provide a detectable trigger for TNF-cx and iNOS in BMMo primed with interferon (IFN) y, 
but still failed to induce IL-12. Thus IL-12 induction is selectively impaired after infection, 
whereas activation pathways for other monokine responses remain relatively intact. Selective 
and complete inhibition of IL-12(p40) induction was observed using BMMo from either ge- 
netically susceptible or resistant mouse strains, as well as IL-10 knockout mice, and was ob- 
tained using promastigotes from cutaneous, visceral, and lipophosphoglycan -deficient strains of 
Leishmania. The impaired production of the major physiologic inducer of lFN-y is suggested to 
underlie the relatively prolonged interval of parasite intracellular survival and replication that is 
typically associate with leishmanial infections, including those producing self-limiting disease. 
eishmania sp. are obligate intracellular protozoa that 
colonize macrophages in the vertebrate host, and their 
control requires the induction of immune responses capa- 
ble of activating macrophages to a microbicidal state. The 
most potent cytokine for the induction of leishmanicidal 
activity in macrophages is IFN-y (1, 2). The sustained pro- 
duction of IFN-y in response to infection is commonly as- 
sociated with the development of specific Thl  and CD8 + 
T cell responses, whereas NK cells have been identified as 
an important, though more transient source of this cyto- 
kine (reviewed in reference 3). Parasites that are able to 
compromise the induction or function of IFN-y are un- 
doubtedly favored for transmission since organisms able to 
attain high parasitemias nd/or to persist in the vertebrate 
host will be more likely to encounter their phlebotomine 
vectors. 
Considering the central role ofmacrophages in the initi- 
ation as well as effector functions of the immune response, 
infection of these cells might impair their ability to provide 
the appropriate regulatory cytokines for enhanced produc- 
tion of IFN-% Recent studies indicate that IL-12 plays an 
important role in potentiating cell-mediated immune re- 
sponses during leishmanial infection. IL-12 is a heterodimeric 
cytokine produced primarily by monocytes, macrophages, 
and B cells, that stimulates growth of Thl  and NK lym- 
phocytes and induces ynthesis of lFN-y by these cells (4-6). 
In models of murine leishmaniasis, treatment of susceptible 
BALB/c mice with rlL-12 rendered these animals resistant 
to L. major by upregulating IFN-~/ and simultaneously in- 
hibiting Th2 cytokine production (7, 8). In vivo adminis- 
tration of IL-12 in mice also potentiated the efficacy of a 
killed vaccine for L. major (9) and provided effective ther- 
apy for an established systemic infection with L. donovani 
(10). In vitro and in vivo experiments have demonstrated 
the crucial role of IL-12 in initiating and establishing both 
innate immunity and T cell-mediated resistance to other 
intracellular pathogens, including Toxoplasma gondii, Listeria 
monocytogenes, and Mycobacterium tuberculosis (11-14). Expo- 
sure ofmacrophages to these organisms results in strong in- 
duction oflL-12 in vitro. In contrast, L. major fails to elicit 
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cytokine synthesis (including IL-12) by macrophages in 
vitro, (15-17), and this has been suggested as an important 
strategy to delay the onset of  strong IFN-~/product ion and 
macrophage activation during the early stages of infection (15). 
In the present studies, we ask whether cytokine re- 
sponses by macrophages are induced, avoided, or actively 
impaired uring in vitro infection with metacyclic promas- 
tigotes of  different strains of Leishmania. Our approach was 
to follow the kinetics of  cytokine responses by bone mar- 
row-der ived macrophages (BMMo) 1 exposed to Leishmania 
promastigotes alone, or in combination with microbial 
stimuli known to activate cytokine gene expression by 
these cells. The responses examined included the proin- 
flammatory cytokines IL-loL, IL-l[3, and TNF-oL; the 
monocyte chemoattractant protein (MCP-1/JE); inducible 
NO synthase (iNOS); and the immunomodulatory c to- 
kines IL-12 and IL-10. Our  findings support he hypothesis 
that in contrast o other intracellular pathogens, Leishmania 
promastigotes fail to induce strong monokine responses 
generally, but that only the absence of IL-12(p40) mRNA 
expression and IL-12 release is due to an active and power-  
ful inhibition of its induction. The selective impairment of lL -  
12 induction might underlie the early progression but 
eventual control that is characteristic of leishmanial infec- 
tions in the vertebrate host. 
Materials and Methods 
Macrophages. Female BALB/c, C3H/HeN, and C57BL/6N 
036), mice 8-12-wk old, were obtained from the Division of 
Cancer Treatment, National Cancer Institute (Frederick, MD). 
The B6 IL-10-deficient (knockout) mice have been previously 
characterized (18). BMMo were recovered following a previously 
published protocol (19), with minor modifications. Briefly, fe- 
murs were flushed with HBSS containing 25 mM Hepes and 50 
I~g/ml gentamycin sulfate, using a 27-in gauge needle. Bone 
marrow ceils were washed once and resuspended in DMEM sup- 
plemented with 10% HI-FCS, 30% L929 cefl-conditioned me- 
dium (source of M-CSF), 100 mM sodium pyruvate, 0.1 mM 
NEAA, 2 mM g-glutamine, 100 U/m1 penicillin, 100 mg/ml 
streptomycin, and 50 ~g/ml gentamycin. Differentiated MO 
were allowed to adhere overnight in 75 cm 2 culture flasks. Non- 
adherent cells were removed and plated (3 plates/mouse) in 3.5 
cm polystyrene culture-treated petri dishes and incubated for 7 d 
at 37~ and 5% CO2. 1 d before infection, cells were washed 
twice and replenished with complete medium without L929 su- 
pernatants. 
Parasites. L. major clone V1 (MHOM/IL/80/Friedlin) and 
L. donovani 1S strain (MHOM/SD/001S-2D) and its derived li- 
pophosphoglycan (LPG)-deficient mutant, R2D2, (20) were cul- 
tured in 199 medium supplemented with 20% HI-FCS, 100 U/ml 
penicillin, 100 Ixg/ml streptomycin, 2 mM L-glutamine, 40 mM 
Hepes, 0.1 mM adenine (in 50 m/Vl Hepes), 5 btg/ml heroin (in 
50% triethanolamine), and 1 ~g/ml 6-biotin (in 95% EtOH). In- 
~Abbreviations used in this paper: BMMo, bone marrow-derived macro- 
phages; HPRT, hypoxanthine-guanine phosphoribosyl t ansferase; iNOS, 
inducible nitric oxide synthase; LPG, lipophosphoglycan; MCP-I/JE, 
monocyte chemoattractant protein; Mtb, Mycobacterium tuberculosis; PKC, 
protein kinase C; STAg, soluble antigen from Toxoplasma gondii. 
fective-stage promastigotes (metacyclics) of L. major were isolated 
from stationary cultures (5-6 d old) by their lack of agglutination 
by peanut agglutinin (PNA) (21). The L. donovani promastigotes 
were obatined from unselected stationary cultures. Before infec- 
tion, promastigotes were opsonized with 5% C5-deficient serum 
obtained from B10.D2/OsNj mice, by incubation at 37~ for 
30 rain. 
Macrophage Infections and Activation. For determination f cy- 
tokine responses in infected macrophages, parasites were used at a 
parasite/macrophage ratio of 20:1. LPS (Sigma Chemical Co., St. 
Louis, MO) was used in all the experiments ata concentration f
10 ng/ml. Recombinant mouse IFN-~ was used at 100 U/ml. 
Heat killed M. tuberculosis was kindly supplied by Drs. Patrick 
Brennan and Andrea Cooper (Colorado State University, Fort 
Collins, CO) and used at three different concentrations: 1,000, 
100, and 10 bacteria/macrophage). Soluble antigen from T. gondii 
(STAg) was prepared as described (22) and used at 10 ~g/ml. The 
stimuli were either added to macrophages alone, or simulta- 
neously with parasites for 2, 6, and 8 h before harvesting superna- 
tants or addition of RNAzol for extraction ofmRNA. 
mRNA Detection by RT-PCR. mRNA detection for the cy- 
tokines IL-llx, IL-113, TNF-o~, IL-10, and IL-12(p40), the [3-che- 
mokine MCP-1/JE, iNOS, as well as a housekeeping ene, 
hypoxanthine-guanine phosphoribosyltransferase (HPRT), were 
performed using a semiquantitative RT-PCR method previously 
described (23), with minor modifications. Briefly, at various times 
after incubation with parasites or stimuli, RNAzol was added di- 
rectly to the petri dishes, and RNA extracted from the BMMo 
following the manufacturer's ecommendations. 1 Ftg of RNA 
was reverse transcribed using Moloney murine leukemia virus 
reverse transcriptase (GIBCO BRL, Gaithersburg, MD). Samples 
were denatured at 70~ for 5 min before the addition of the en- 
zyme and were then incubated 1 h at 60~ and 5 rain at 90~ to 
inactivate the enzyme. After cooling on ice for 3 rain, samples 
were diluted in distilled water to a final volume of 200 p~l (1:8) 
and stored at -20~ 10 ~1 of this solution was used for amplifica- 
tion in a semiquantitative PCR with Taq I Polymerase (Promega 
Corp., Madison, WI). Samples were incubated for 3 min at 95~ 
and were then amplified with an experimentally determined opti- 
mal temperature cycle number of (94~ for 1 min, 54~ for 1 
rain, and 72~ for 2 min) for each cytokine mRNA. 24 cycles 
were used for HPRT, IL-lo~, IL-I~, TNF-~x, and JE; 35 for 
iNOS; 40 for IL-12(p40); and 30 cycles for IL-10. PCR products 
were Southern blotted, transferred to Hybond + membranes (Am- 
ersham Corp., Arlington Heights, IL), and probed with cytokine- 
specific fluorescein-labeled oligonucleotides. The enhanced chemi- 
luminescent (ECL) detection system (Amersham Corp.) was used 
for detection, exposing the membranes to byperfilm (Amersham 
Corp.) at room temperature. The signals were analyzed using a 
densitometrical optical scanner (model 600ZS; Microteck, Tor- 
rance, CA) and Image software (National Institutes of Health, 
Bethesda, MD). Results were expressed as fold increase over con- 
trol, considering the control value as one unit. 
The primers and probes used for amplification and detection 
were as described for IL-hx, IL-113, and TNF-~x (23); for IL-10 
and HPRT (24); for iNOS (22) and IL-12(p40) (25); and forJE (26): 
HPRT: 5'-GTTGGATACAGGCCAAGACTTTGTTG; 3'-GAT- 
TCAACTTGCGCTCA-TCTTAGGC; probe GTTGTTGGAT- 
TGCCCTTGAC; IL-loc 5'-TGAGATTTTTAGAGTAACAGG; 
3'-GGAAGATTGTCAAGAAGAGACGG; probe CCAGAT- 
CAGCACCTTACACC; IL-113: 5'-GGGATGATGATGATA- 
ACCTG; 3'-TTGTCGTTGCTTGGTTCTCCT; probe CAG- 
CTGCACTACAGGCTCCG; TNF-~x: 5'-CTCCAGCTGGA- 
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AGACTCCTCCCAG; 3'-GATCTCAAAGACAACCAACTA- 
GTG; probe CCCGACTACGTGCTCCTCACC; iNOS: 5'-CTG- 
GAGGAGCTCCTGCCTCATG; 3' -GCAGCATCCCCTCT- 
GATGGTG; probe CTGGATGAGCTCATCTTTGCC; IL-12 
p40: 5'-CGTGCTCATGGCTGGTGCAAAG; 3'-CTTCAT- 
CTGCAAGTTCTTGGGC; probe TCTGTCTGCAGAGAA- 
GGTCACA; IL-10: 5'-CGGGAAGACAATAACTG; 3'-CAT- 
TTCCGATAA.GGCTTGG; probe GGACTGCCTTCAGCC- 
AGGTGAAGACTTT; JE: 5'-TCAGCCAGATGCAGTTAACG; 
3'-CAAGAAGGAATGGGTCCAGA; probe TCACCAGCAA- 
GATGATCCCAATGAG. 
Cytokine Detection Assays. TNF-ot was determined by mea- 
suring the cytotoxicity to TNF-sensitive L929 cells of macro- 
phage supematants recovered 6 h after infection and/or treatment 
(25). Murine (Mu) rTNF-ot was used as standard. IL-12 was as- 
sayed in 6-h supernatants by a two-site RIA. Briefly, 96-well 
plates were coated overnight with 5 p~g/ml C15.1.2 Ab in so- 
dium carbonate/bicarbonate buffer (pH 9.5). Plates were washed 
three times with PBS/0.05% Tween 20. Standard and samples 
were added to the plates, incubated overnight, washed again with 
PBS/Tween and incubated for 6 h with 12SI-labeled C15.6.7 Ab. 
Bound radioactivity was assessed by scintillation counting and the 
amount oflL-12 calculated by reference to a standard curve gen- 
erated using rMulL-12 (Genetics Institute, Cambridge, MA). IL-1 
was measured as described (27) using the IL-let/[3-dependent cell 
line T1165.17, obtained from Dr. A. Glasebrook (Eli Lilly, India- 
napolis, IN) and Dr. Richard Titus (Colorado State University, 
Ft. Collins, CO). The cells were maintained in DMEM plus 5% 
FCS supplemented with human rlL-lot (R&D Systems, Inc., 
Minneapolis, MN). Cells were plated at 5,000 per well in dupli- 
cate wells in 96-well flat bottom plates and test supernatant was 
added to a final volume of 200 ~1. After a 42-h incubation at 
37~ 5% CO2, the plates were pulsed for 6 h with 1 p, Ci 
methyl-[3H]thymidine (5 Ci/mmol) (Amersham Corp.). Prolifer- 
ation was determined by scintillation counting, and levels were 
calculated by reference to a standard curve constructed with 
rMulL-lot. 
Resu l ts  
Kinetics of Cytokine mRNA Expression in BMMo from 
BALB/c Mice Stimulated with LPS, Mtb, or L. major Promas- 
tigotes. The kinetics of  mtkNA expression for TNF-ot, 
IL-lot, IL-1]3, IL-12(p40), MCP-1/ JE ,  IL-10, and iNOS 
after exposure to either LPS, Mtb, or serum-opsonized 
L. major metacyclic promastigotes, are shown in Fig. 1, ex- 
pressed as fold increase over untreated control. Both LPS 
and Mtb induced strong mRNA expression for each of  the 
genes analyzed. The peak signal for each cytokine was al- 
ways greater in response to Mtb, except IL-12(p40), for 
which the LPS- and Mtb- induced signals were roughly 
equivalent. Whereas positive signals were seen by 2 h, in 
each case the peak signals were seen at 6 h after treatment, 
with the exception of  I L - I~ and IL-10, which displayed 
equivalent or slightly stronger signals at the earlier time 
point. By 18 h, transcript levels of  each of  the genes had re- 
turned to just above baseline, again with the exception of  
IL-113, which maintained strong expression at each of  the 
time points studied. In contrast o LPS and Mtb, L. major 
promastigotes seemed to largely avoid activation of  BALB/c 
BMMo,  despite their efficient attachment to and uptake by 
these cells (more than 90% of cells infected, more than 
three promastigotes per cell). No  positive signals were de- 
tected for either IL-lot, IL-1[3, IL-12(p40), or iNOS at any 
of  the time points studied. A weak signal for TNF-ot, and 
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Figure 1. Kinetics of mRNA 
expression in BMMo from 
BALB/c mice exposed to LPS 
(open squares), high dose-killed 
Mtb (closed squares), or L. major 
metacyclic promastigotes (clo ed 
triangles), mRNA levels are ex- 
pressed relative to levels in 
untreated control cells at each 
time point (given an arbitrary 
value of 1). 
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Figure 2. Effect of L. major metacyclic promastigotes 
on LPS- and Mtb-induced expression of cytokine 
mRNA. BMMo from BALB/c mice were exposed to L. 
major metacyclics (Lm), LPS, or killed Mtb at 1,000, 10(t, 
and 10 bacteria/macrophage (Mtb 1, 2, and 3), added ei- 
ther alone orat the same time, as indicated. Semiquanti- 
tative RT PCR was done on RNA from each sample, 
and the products were visualized after Southern t ansfer. 
mRNA levels obtained after 6 h of incubation are shown 
for each of the cytokines, except for IL-10, for which the 
2-h time point isshown. Results are representative of six 
separate experiments. 
weak but consistent signals for IL-10 andJE were observed 
at 2 h, declining to baseline by 6 h. These signals were no 
stronger when examined at 1 and 24 h (data not shown). 
Effect of L. major Infection on LPS- and Mtb-induced BMMo 
Activation. The effect of  leishmanial infection on either 
LPS- or Mtb-induced mRNA expression in BMMo from 
BALB/c mice was examined in separate xperiments at 6 h 
after treatment for IL-lcx, IL-1]3, TNF-ot, iNOS, and IL- 
12(p40), and at 2 h for IL-10. Again, the parasite alone in- 
duced no detectable proinflammatory cytokine mRNA,  
except for very weak expression of  TNF-er (Fig. 2). In 
contrast, parasite activation of  IL-10 message was relatively 
strong in these experiments. LPS and Mtb, at each of the 
three doses tested, induced strong expression of  all cyto- 
kine genes, with the exception of  IL-10, which was only 
weakly expressed after 2 h in response to LPS. The effect 
of  the parasite on these responses was a partial inhibition of  
IL-l(x, IL-1[3, TNF-(x, and iNOS, a strong inhibition of 
IL-12(p40), and potentiation of  lL-10. The IL-12(p40) re- 
sponse to LPS was completely inhibited, as was the IL- 
12(p40) response to the lowest concentration of Mtb. The 
opposite effects that the promastigotes had on IL-12(p40) 
and IL-10 mRNA induction are more quantitatively repre- 
sented in Fig. 3, which, after normalizing for input RNA,  
confirms the virtually complete inhibition of the IL- 
12(p40) response to LPS and lower doses of Mtb, and re- 
veals in addition a strong inhibition of the response to even 
the highest concentration of Mtb. The upregulation of 
IL-10 is significant at the lower doses of  Mtb. 
L. major Promastigotes Evade Cellular Activation of BMMo 
from Genetically Resistant As Well As Susceptible Mouse Strains. 
The differential effects that the parasite has on cytokines 
known to regulate the development of  distinct CD4 + T 
cell subsets uggested a possible mechanism to explain the 
preferential activation of  Th2 ceils that occurs in response 
to L. major infection in susceptible BALB/c mice. To ex- 
plore this possibility further, BMMo from BALB/c as well 
as genetically resistant B6 and C3H mice were compared 
for their responses to the parasite alone or in combination 
with LPS or Mtb. Infection with L. major promastigotes 
failed to induce expression ofIL-lcl ,  TNF-ix, or IL-12(p40) 
in cells from either susceptible or resistant mice (Fig. 4). 
IL-10 mRNA also was not detected, although in these ex- 
periments only the 6-h time point was analyzed. Low levels of 
parasite-induced transcripts for JE were detectable in cells 
from BALB/c and B6 mice. The effects of  the parasite on 
LPS- and Mtb-induced responses were also similar in the 
three mouse strains. Slight inhibition of  IL-l~x and TNF-o~ 
was accompanied by complete inhibition of both LPS- and 
Mtb-induced IL-12(p40) expression in all three mouse 
strains. Upregulation of  IL-10 and JE also occurred in the 
three mouse strains. 
The levels ofIL- lci ,  TNF-or and IL-12 contained in the 
BMMo culture supernatants were also determined for the 
three mouse strains (Table 1). TNF-oL and IL-12 were 
measured in 6-h supernatants from the same cells used for 
mRNA analyses. Reliable assay of  IL-1 required longer in- 
cubation, and was determined from a separate xperiment 
in which supernatants were harvested at 18 h. The protein 
levels closely reflected the pattern of mRNA expression 
determined by RT-PCR.  LPS and Mtb elicited good pro- 
duction of the three cytokines by cells from all three mouse 
strains. These cytokines were not detectable in supernatants 
from the cells exposed to L. major promastigotes alone, save 
for the relatively high levels of IL-lcx/[3 produced by the 
infected cells from C3H mice. Furthermore, the parasite 
completely inhibited (to background levels) the LPS- and 
Mtb-induced IL-12 production by cells from all three 
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mouse strains. In contrast, TNF-o~ product ion was only re- 
duced by half or not at all, and IL-1 product ion was actu- 
ally enhanced, again with comparable ffects observed in all 
three mouse strains. Thus the selective ffects that the para- 
site has on IL-12(p40) gene expression and product ion 
seem not  to be related to the long-term outcome of  infec- 
t ion in these mouse strains. 
Leishmania Promastigotes Evade Triggering IL-I2 Production 
in BMMo Primed with IFN-T. Macrophages are consid- 
ered fully activated when they receive both "pr iming" and 
"triggering" stimuli, which in experimental systems typi- 
cally have been provided by IFN-y  and LPS, respectively 
(28). I f  the parasite's inability to activate macrophages for 
cytokine expression were due to defects confined largely to 
macrophage priming, then provision of  this signal might 
reveal a triggering stimulus associated with infection. This 
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Figure 4. Effect of L. major 
metacyclic promastigotes on LPS- 
and Mtb- (100 bacteria~macro- 
phage) induced expression of cyto- 
kine mRNA by BMMo from 
BALB/c, C3H/HeN, and C57BL/6 
mice. Cells were harvested for RNA 
at 6 h. Dashes indicate samples for 
which no data was obtained. Re- 
sults are representative of two ex- 
periments. 
Tab le  1. Effect of L. major Metacyclic Promastigotes onLPS- and Mtb-induced Cytokine Release by BMMo from Susceptible 
and Resistant Mice 
TNF-~* I L - lod~ IL-12" 
C57BL/6 C3H BALB/c C57BL/6 C3H BALB/c C57BL/6 C3H BALB/c 
U/ml U/ml pg/ml 
control 0 0 0 6 0 0 135 141 130 
LPS 0 1,920 1,920 230 160 3l 1,306 1,406 996 
Lm 0 0 0 0 210 0 t45 139 171 
Lm/LPS 480 960 960 1,062 382 78 187 186 191 
Mtb 1 480 1,920 1,920 ND ND ND 710 531 854 
Lm/Mtb 1 480 960 1,920 ND ND ND 196 160 l 81 
Mtb 2 480 960 1,920 400 30 52 1,109 724 1,039 
Lm/Mtb 2 480 960 960 1,765 140 179 154 130 190 
* 6-h supernatants. 
* 18-h supernatants. 
possibility was investigated in BMMo from B6 mice ex- 
posed simultaneously to IFN-~ and various microbial stim- 
uli. Levels of  mRNA were determined at 6 h, and are 
shown in Fig. 5 for TNF-ot, iNOS, and 'IL-12, each of  
which has been shown to be upregulated by IFN-~/ (14, 
22, 29). Costimulation with IFN-',/ increased signals for 
TNF-ix, iNOS, and especially IL-12(p40) in response to 
LPS, Mtb, and STAg. Costimulation with IFN-y  also up- 
regulated mRNA expression for TNF-ot and iNOS in cells 
infected with L. major, indicating that at least for some re- 
sponses, the parasite can provide a measurable stimulus so 
long as the cells are adequately primed. In contrast, priming 
with IFN-y  had no effect on the IL-12(p40) response to 
the parasite, which remained undetectable. The protein 
data for this experiment is shown in Table 2. Priming with 
IFN-2r increased IL-12 production induced by LPS, Mtb, 
and STAg by approximately twofold. The IL-12 produced 
in response to L. major promastigotes remained at back- 
ground levels even in the presence of IFN-'y. Preexposure 
of  the BMMo to IFN-y  for 18 h before as well as during 
infection still failed to induce IL-12 (data not shown). The 
ability of  IFN-3, to upregulate TNF-ot production was ap- 
parent only for the response to Mtb, although the biologi- 
cal assay failed to detect TNF-tx released in response to 
those stimuli for which the mRNA signals were weak. 
The Downregulation of lL-12 Induction by L. major Promas- 
tigotes Is Not IL-IO Dependent. IL-10 was originally de- 
scribed as a factor produced by Th2 cells that inhibited the 
synthesis of  cytokines by Th l  cells (30). It has since been 
shown to be produced by other cell types, including Ly-1 
B cells, mast cells, and macrophages, and its effects on IFN-y  
production have been shown to be through an inhibition 
of  macrophage accessory cell function rather than a direct 
interaction with IFN-' , / -producing cells (31). IL-10 has 
been found to inhibit the production of  proinflammatory 
F igure  5. Induction of cytokine mRNA in BMMo from C57BL/6 
mice exposed to L. major metacyclic promastigotes, M b (100 bacteria/ 
macrophage), or soluble antigen from T. gondii (STAg), during priming 
with IFN-"/. RNA was harvested for RT-PCR 6 h after treatment. Re- 
sults are representative of two experiments. 
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Table 2. Effect of Priming with IFN-T on Cytokine Release by BMMo fiom C57B1/6 Mice Exposed toL. major Metacydic Promastigotes 
and other Microbial Stimuli 
Media IFN-'y LPS IFN-',//LPS Lm IFN-',//Lm Mtb IFN-',//Mtb STAg IFN-'y/STAg 
IL-12 (pg/ml) 172 132 4,079 8,940 259 171 2,055 3,733 289 594 
TNF-c~ (U/ml) 0 0 240 240 0 0 480 960 0 0 
cytokines by macrophages, including TNF-tx, IL-1, IL-6, 
and IL-12 (32). As IL-10 mRNA expression was stimulated 
early in infection (2 h) by L. major promastigotes, and its 
induction by LPS or Mtb was also upregulated by the para- 
site, the possibility that IL-10 might be responsible for the 
downregulation of  IL-12 synthesis during infection was as- 
sessed by analysis oflL-12(p40) mR.NA induced in BMMo 
from IL-10 knockout C57BL/6 mice (Fig. 6). The lack of  
detectable IL-10 transcripts in the activated cells from the 
knockout mice is consistent with the fact that the 5' primer 
sequence used to amplify IL-10 cDNA binds within the 
first exon, which has been replaced by a neomycin gene 
in the knockout mice (18). In both the knockouts and the 
wild-type controls, no IL-12(p40) mRNA was seen in 
response to the parasite alone, and in both strains the LPS- 
and Mth-induced expression of the gene was strongly in- 
hibited by the parasite (Fig. 6). The apparent greater inten- 
sity of  the residual IL-12(p40) signals observed in the 
knockout cells was found to be comparably reduced when 
normalized and expressed as fold increase over control. The 
lack of any difference between the strains is reinforced by 
the IL-12 levels in the culture supernatants. For the wild- 
type cells, LPS- and Mtb-induced IL-12 production was 
reduced by the parasite from 2,892 and 1,413 pg/ml, re- 
spectively, to 263 and 202 pg/ml. However, for the IL-10 
knockout cells, the values for IL-12 were reduced from 
3,982 and 2,300 pg/ml to 165 and 97 pg/ml. 
The Ability of Promastigotes to Inhibit IL-12 Activation Is 
Not Dependent on Expression of the Abundant Surface Lipo- 
phosphoglycan. LPG is the major surface glycoconjugate of 
Leishmania promastigotes and has been implicated in the 
downregulation of protein kinase C (PKC)-mediated signal 
transduction in macrophages (33). To determine whether 
LPG plays a role in the inhibition of activation signals lead- 
ing to IL-12(p40) expression, the Mtb-induced mtLNA re- 
sponses in BMMo from BALB/c mice were examined in 
the presence of  stationary phase promastigotes of  L. major, 
L. donovani, and an LPG-deficient mutant of L. donavani, 
termed P,2D2. The effects of these parasites on cytokine 
gene expression were similar in each case (Fig. 7). The re- 
sponses induced by the parasites themselves were negligi- 
ble, save for the low expression of  TNF-ot. Their inhibi- 
tory effects on Mtb-induced IL-1, TNF-oL, and iNOS 
expression were slight in each case (the absence of  an iNOS 
signal was not observed in a subsequent experiment), whereas 
each was able to completely inhibit expression oflL-12(p40). 
Finally, each strain was able to significantly upregulate the 
IL-10 response. Thus, the requirement for LPG in the dif- 
ferential effects on cytokine gene expression can be ruled 
out, although the data do not preclude a requirement for 
glycolipids structurally related to LPG which are still ex- 
pressed by the R.2D2 mutant. 
Figure 6. Effect of L. major metacyclic promastigotes on LPS- and 
Mtb- (100 bacteria/macrophage) induced expression of IL-12 a d IL-10 
mILNA by BMMo from wild-type C57BL/6 and IL-10 knockout mice. 
RNA was harvested for kT-PCP, 6 h after treatment. The signals ex- 
pressed as fold increase are shown for IL-12 only (solid bars, IL-IO knock- 
outs; hatched bars, wild-type). Results are representative of three experi- 
ments. 
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Discussion 
Cells of the macrophage lineage play a pivotal role in the 
development of immune responses to microorganisms, in
part through the processing of  microbial antigens for pre- 
sentation to T cells, through the expression of cell surface 
costimulatory molecules, and through the release of immu- 
noregulatory cytokines. The ability of infected macro- 
Figure 7. Effect of stationary phase promastigotes of L. major (Lm), L. 
donovani (Ld), or the LPG-deficient L. donovani mutant (R2D2) on LPS- 
and Mtb- (100 bacteria/macrophage) induced expression of cytokine 
mRNA by BMMo from BALB/c mice. P,.NA was harvested for RT- 
PCP,. 6 h after treatment. 
phages to present leishmanial antigens to T cells and to 
drive their activation iswell supported (34-36). The present 
data argue that infected macrophages will drive early T cell 
activation in the absence of IL-12, thereby avoiding the 
major physiologic inducer for Thl  development, elevated 
production of IFN-% and activation of macrophages to a 
microbicidal state. The findings are essentially in agreement 
with those of R, einer et al. (15), who proposed that Leish- 
mania promastigotes avoid initiating activation signals for 
inflammatory and immunodulatory cytokines generally, 
and IL-12 in particular, and in this way the survival of the 
parasite in the vertebrate host is prolonged. The present 
studies extend these observations by demonstrating that 
whereas the attachment to and entry of Leishmania promas- 
tigotes into macrophages proceeds in a remarkably silent 
manner, of the various cytokine responses examined, only 
the induction of IL-12(p40) was found to be actively im- 
paired. 
Infection of BMMo with serum-opsonized L. major 
metacyclic promastigotes failed to induce detectable l vels 
of mRNA for most of the cytokine genes studied. Weak 
but positive signals for IL-10 and JE were consistently ob- 
served, especially when the response was examined early. 
Infection of BMMo during exposure to microbial stimuli 
known to initiate strong activation signals resulted in three 
general effects: (a) strong, and in most cases, complete inhi- 
bition of IL-12(p40) mRNA and protein synthesis; (b) par- 
tial, and in most cases, weak inhibition of mP,.NA and/or 
protein for IL-tx, IL-lJ3, TNF-~x, and iNOS; and (c) upreg- 
ulation of mIkNA for IL-10 and MCP-1/JE. These out- 
comes suggest that IL-12 production is tightly regulated by 
an activation pathway(s) that is selectively and efficiently 
compromised by Leishmania promastigotes during infec- 
tion. The involvement of several alternative induction 
pathways for TNF-0t and IL-~ (28, 37, 38) suggests a basis 
for the partial inhibition of these cytokines during leishma- 
nial infection, in which only the pathway(s) common to 
IL-12(p40) induction might be impaired. 
Selective inhibition of IL-12 synthesis was also observed 
when BMMo were treated with IFN-% which revealed 
that the parasite could provide a detectable stimulus for 
TNF-ix and iNOS gene expression i  primed cells, but still 
failed to provide a trigger for IL-12. In contrast, exposure 
of the cells to LPS, killed Mtb, or STAg during priming 
with IFN-',/ resulted in significantly upregulated synthesis 
of TNF-o~, iNOS, and especially IL-12. The ability of 
Leishmania-infected cells to be activated by IFN-~ for in- 
tracellular killing, either alone or in combination with 
other stimuli, is well described (1, 2, 29). The data suggest 
that the inability of the parasite to induce certain cytokines 
during infection is due less to the fact that relevant induc- 
tion pathways are disrupted than to the fact that the parasite 
alone is unable to provide both the priming and triggering 
stimuli required for their expression. Other investigators 
have reported that even primary exposure of macrophages 
to Leishmania, either amastigotes orpromastigotes, results in 
release of significant levels of IL-1 or TNF-o~ (27, 29, 39, 
40). It is not clear why in our studies and that of others (41) 
the parasite alone failed to stimulate production of these 
cytokines, although differences in the subpopulation of the 
macrophages u ed and/or LPS contamination are possible 
explanations. These data, nonetheless, reinforce the con- 
clusion that Leishmania-infected cells retain the potential to 
produce most of the cytokines involved in inflammatory 
and effector functions, including those mediated by IFN-~/. 
The reciprocal effects that the parasite has on IL-12 and 
IL-10 production by BMMo does not seem to explain the 
preferential ctivation of Th2 cells during infection of ge- 
netically susceptible BALB/c mice, since identical out- 
comes were observed using BMMo from resistant C57BL/6 
and C3H mice. In addition, these effects were not confined 
to Leishmania species with particular clinical associations, 
since they were seen using both L. major and L. donovani 
promastigotes. The avoidance of IFN-~ induction path- 
ways might, instead, underlie the relatively prolonged u- 
ration of parasite survival and amplification that is charac- 
teristic of leishmanial infections generally, whether they be 
self-healing or progressive, cutaneous or visceral. Unlike 
the rapidly self-limiting infections produced by other intra- 
cellular pathogens, uch as Mycobacteria, Listeria, Cryptospo- 
ridia, or Toxoplasma, the self-limiting infections caused by 
Leishmania require weeks or months to resolve. Leishmania 
strains able to amplify their numbers by delaying the onset 
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of host control mechanisms clearly will be favored for 
transmission. This may be especially true for parasites pro- 
ducing localized cutaneous or mucosal disease, which will 
have infrequent encounters with their phlebotomine v ctors. 
There is considerable evidence that the delayed onset of 
heating typically seen i self-limiting forms of leishmanial 
disease is due to the slow development of cell-mediated 
immune response (i.e., delayed production of IFN-~), 
rather than, as has been suggested (42), the inability of in- 
fected cells to be activated for killing (that is, impaired 
response to IFN-~/). For example, patients are susceptible 
to reinfection during the active stages of cutaneous disease, 
whereas they are resistant after healing has commenced (43, 
44, and reviewed in reference 45). Experimentally, evi- 
dence for defective IL-12 induction by Leishmania is sug- 
gested by studies in scicl mice, which are capable ofproduc- 
ing a T cell-independent, IL-12-dependent IFN-~/response 
to a variety of intracellular bacteria nd parasites, including 
L. monocytogenes, Corynebacterium parvum, Salmonella, Myco- 
bacteria, and T. gondii (12, 25, 46). In contrast, L. donovani 
promastigotes failed to initiate an NK cell-derived IFN-~/ 
response in spleen ceils from scid mice, either in vivo or in 
vitro (47). 
Direct evidence for delayed induction of IL-12(p40) 
transcripts during L. major infection was reported by Reiner 
et al. (15) for both susceptible and resistant mouse strains). 
In addition, anti-IL-12 antibodies could be administered to
C57BL/6 mice as late as 2 wk after infection and still exac- 
erbate disease, consistent with delayed production of IL- 12 
(48). In more recent studies (49, 50), delayed production of 
IL-12 in response to L. major was confined to C57BL/6 
mice, whereas C3H and, surprisingly, BALB/c mice, pro- 
duced an elevated IL-12 response within 1 d of infection. 
Whereas the early C3H response was associated with rapid 
control of the parasite, the delayed response in C57BL/6 
mice was associated with larger lesions requiring longer to 
heal. For BALB/c mice, the induction of Thl cells and el- 
evated levels of IFN-~/ by IL-12 was thought o be pre- 
vented by the simultaneous production of inhibitory cy- 
tokines. 
To what extent do the in vitro outcomes using BMMo 
grown in M-CSF conditioned medium and used after 6-7 d 
of adherence, which represent relatively heterogeneous 
populations of differentiated cells, reflect he in vivo expe- 
rience with high doses of subcutaneously inoculated para- 
sites? The response of BMMo to infection is certainly con- 
sistent with the in vivo outcomes in C57BL/6 mice, which 
arguably model most closely the course of cutaneous leish- 
maniasis in natural hosts. In contrast, the early IL-12 re- 
sponse in C3H and BALB/c mice might be explained by 
strain polymorphisms in the number and tissue distribution 
of distinct macrophage subpopulations, or cell types such as 
B cells, keratinocytes or neutrophils, that are each capable 
of producing IL-12, but that might respond quite differ- 
ently to the parasite or its products. Recent observations 
bear indirectly on this point. When leishmanial antigens 
were presented by GM-CSF-derived macrophages a op- 
posed to M-CSF macrophages, they were able to induce 
523 Carrera etal. 
high levels of IFN-3' and resistance to infection in BALB/c 
mice (51). There is growing evidence from in vitro studies 
that differences in antigen-presenting cell populations can 
influence the pattern of CD4 + subset development (52). 
The ability of a high dose inoculum to stimulate an early 
IL-12 response in certain mouse strains may reflect events 
which are more typically delayed during infection in 
C57BL/6 mice and natural hosts. As the parasite load in- 
creases, the parasite or its products might no longer be con- 
fined to the same cell types targeted by metacyclic promas- 
tigotes at the initiation of infection, such that different 
patterns of regulatory cytokines emerge. 
Although IL-10 was first described as a cytokine that in- 
hibits macrophage-dependent cytokine synthesis by Thl  
cells (30), it does not appear to be involved in downregu- 
lating IL-12 synthesis by infected macrophages since cells 
from IL-10 knockout mice still failed to produce IL-12 in 
response to promastigotes, and were also markedly inhib- 
ited by the parasite for expression of LPS- and Mtb- 
induced IL-12(p40) transcripts and protein. It is possible 
that IL-10 production by infected cells might impair other 
accessory cell functions. IL-10 has been found to downreg- 
ulate expression of B7 and other costimulatory surface mol- 
ecules (53), and this might be related to the recent observa- 
tion that B7 is downregulated on Leishmania-infected cells 
(54). Furthermore, since B7/CD28 interactions synergize 
with IL-12 to induce high levels ofIFN-~/(55, 56), the co- 
ordinate inhibition of both molecules, whether by related 
or independent mechanisms, might ensure that IFN-~/ in- 
duction pathways are avoided. The previously unreported 
possibility that the parasite can directly activate an IL-10 re- 
sponse in macrophages, might explain the source of IL-10, 
which has been found to be associated with certain chronic 
leishmanial infections (57, 58), especially since other Th2- 
associated cytokines were not also seen. 
The possible role of TGF-[3 in IL-12 downregulation 
has not been investigated in these studies but should be 
considered, given the ability of this mediator to potentiate 
Leishmania intramacrophage survival in vitro and in vivo 
(59, 60). TGF-[3 is a suppressor of many known macro- 
phage responses, including the oxidative burst (61), micro- 
bicidal response to IFN-~/ (59), as well as IL-12-initiated 
IFN-~/production by human neonatal CD4 + cells (62). Its 
pleiotropic activities may not, therefore, be consistent with 
the selective ffects that the parasite has on IL-12. Further- 
more, TGF-[3-mediated suppression ofLPS-induced TNF-e~ 
and IL-1 release by macrophages was found to be late act- 
ing (12-16 h; 63); this is not consistent with the defects as- 
sociated with IL-12(p40) induction in infected cells. 
The alternative to agonist-mediated suppression of IL-12 
induction is that the parasite or its products directly inter- 
fere with specific signal-transducing events. There is sub- 
stantial evidence that leishmanial infection selectively impairs 
PKC-dependent signal transduction i  host macrophages 
(64, 65), suggesting that this may be an essential pathway 
for induction of IL-12. Leishmania-infected cells or mac- 
rophages treated with promastigote LPG display defective 
membrane translocation of PKC or defective phosphoryla- 
tion of  endogenous PKC substrates, respectively. It is clear 
that since the LPG-deficient mutant, R2D2, was as inhibi- 
tory for IL-12 induction as the wild-type strain, LPG is not 
required for this effect. This result does not rule out the 
possible role of LPG-related structures, that is, the glyco- 
sylinositolphospholipids (66), which are still abundantly ex- 
pressed by R2D2. The involvement of  PKC-dependent 
signal transduction in IL-12 upregulation and its specific 
disruption by the parasite are currently being explored. 
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